Your browser doesn't support javascript.
loading
Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
Zhang, Shanshan; Akmar, Lily Zainal; Bailey, Freddie; Rath, Barbara A; Alchikh, Maren; Schweiger, Brunhilde; Lucero, Marilla G; Nillos, Leilani T; Kyaw, Moe H; Kieffer, Alexia; Tong, Sabine; Campbell, Harry; Beutels, Philippe; Nair, Harish.
Afiliação
  • Zhang S; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Akmar LZ; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Bailey F; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Rath BA; Vienna Vaccine Safety Initiative, Berlin, Germany.
  • Alchikh M; Vienna Vaccine Safety Initiative, Berlin, Germany.
  • Schweiger B; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany.
  • Lucero MG; Research Institute for Tropical Medicine, Alabang, Muntinlupa City, Philippines.
  • Nillos LT; Research Institute for Tropical Medicine, Alabang, Muntinlupa City, Philippines.
  • Kyaw MH; Sanofi Pasteur, Swiftwater, Pennsylvania, USA.
  • Kieffer A; Sanofi Pasteur, Lyon, France.
  • Tong S; IVIDATA Stats, Levallois-Perret, France.
  • Campbell H; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Beutels P; Universiteit Antwerpen, Antwerpen, Belgium.
  • Nair H; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
J Infect Dis ; 222(Suppl 7): S680-S687, 2020 10 07.
Article em En | MEDLINE | ID: mdl-32227101
ABSTRACT

BACKGROUND:

Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory infection (ALRI) in young children aged <5 years.

METHODS:

We aimed to identify the global inpatient and outpatient cost of management of RSV-ALRI in young children to assist health policy makers in making decisions related to resource allocation for interventions to reduce severe morbidity and mortality from RSV in this age group. We searched 3 electronic databases including Global Health, Medline, and EMBASE for studies reporting cost data on RSV management in children under 60 months from 2000 to 2017. Unpublished data on the management cost of RSV episodes were collected through collaboration with an international working group (RSV GEN) and claim databases.

RESULTS:

We identified 41 studies reporting data from year 1987 to 2017, mainly from Europe, North America, and Australia, covering the management of a total of 365 828 RSV disease episodes. The average cost per episode was €3452 (95% confidence interval [CI], 3265-3639) and €299 (95% CI, 295-303) for inpatient and outpatient management without follow-up, and it increased to €8591(95% CI, 8489-8692) and €2191 (95% CI, 2190-2192), respectively, with follow-up to 2 years after the initial event.

CONCLUSIONS:

Known risk factors (early and late preterm birth, congenital heart disease, chronic lung disease, intensive care unit admission, and ventilator use) were associated with €4160 (95% CI, 3237-5082) increased cost of hospitalization. The global cost of inpatient and outpatient RSV ALRI management in young children in 2017 was estimated to be approximately €4.82 billion (95% CI, 3.47-7.93), 65% of these in developing countries and 55% of global costs accounted for by hospitalization. We have demonstrated that RSV imposed a substantial economic burden on health systems, governments, and the society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 11_ODS3_cobertura_universal / 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Saúde Global / Efeitos Psicossociais da Doença / Infecções por Vírus Respiratório Sincicial / Hospitalização Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Child / Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 11_ODS3_cobertura_universal / 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Saúde Global / Efeitos Psicossociais da Doença / Infecções por Vírus Respiratório Sincicial / Hospitalização Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Child / Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2020 Tipo de documento: Article